Articles / The Real Story on a COVID-19 vaccine
These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.
These are activities that require reflection on feedback about your work.
These are activities that use your work data to ensure quality results.
These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.
These are activities that require reflection on feedback about your work.
These are activities that use your work data to ensure quality results.
This week’s expert: Prof Ian Frazer, Clinical Immunologist; Researcher for Vaccine Development, Faculty of Medicine, The University of QLD.
Drawn from an interview with Clinical Immunologist Prof Ian Frazer by Dr Harry Nespolon on the Healthed podcast Going Viral.
• Based on our knowledge about immunisation against other coronaviruses both in animals and humans, if we do get a vaccine against SARS-CoV-2, it is unlikely to be highly immunogenic or confer long-term immunity.
• The major challenge exists because SARS-CoV-2 affects the respiratory tract, where the immune system is distinct from the rest of the body. Currently the problem is that we are trying to get a vaccine that is delivered systemically to specifically and significantly affect the immune system in the respiratory tract.
GLP-1 Prescribing Expert Panel Discussion
Arrhythmia Management in Primary Care
Infant Allergy Cases
Yes, if the referral process involves meaningful collaboration with GPs
Yes
No
Listen to expert interviews.
Click to open in a new tab
Browse the latest articles from Healthed.
Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.
Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.